Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FBGK4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,843
Award facts
- Contract value 100% obligated
- $23,843.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,843.31 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026. The contract place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this award.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The SPE2DX prime vendor contract functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Zepbound, a GLP-1 receptor agonist medication for weight management, exemplifies the company's role in fulfilling Defense Health Agency and military healthcare requirements through the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FBGK4?
SPE2DB25FBGK4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FBGK4 worth?
The government has obligated $23,843 on SPE2DB25FBGK4.
Is contract SPE2DB25FBGK4 an order under another contract?
Yes. SPE2DB25FBGK4 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBGK4 competed?
The extent of competition for SPE2DB25FBGK4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award